InsidersTradesSigma
Track the 東和薬品株式会社 stock price and the full insider trade history of the company, a publicly traded company based in Japan. Shares trade on the JP market, under the supervision of EDINET (Japan FSA). Operating in the Health Care sector, 東和薬品株式会社 has recorded 3 reports. Market capitalisation: €186.3bn. The latest transaction was reported on 6 July 2026 (Holding update). Among the most active insiders: Sumitomo Mitsui DS Asset Management Company, Limited. Every trade is free.
Analysts rate 東和薬品株式会社 Strong Buy (bullish), based on 6 analysts. Average price target: JP¥5,233.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Towa Pharmaceutical Co., Ltd. es una empresa japonesa especializada en el sector farmacéutico. Se enfoca en la investigación, desarrollo y comercialización de medicamentos.